Previously approved medications that have gained new FDA approval for the treatment of additional medical conditions.
New and old treatments for malignant mesothelioma: not just immunotherapydoi:10.1016/S2213-2600(20)30516-6Anna K NowakThe Lancet Respiratory Medicine
Clinical activity was observed with an overall disease control rate of 35% and 4 confirmed responses in mesothelioma, ovarian cancer, atypical lung neuroendocrine tumour, and intrahepatic cholangiocarcinoma. Across all tumours, multimodal analyses of paired patient biopsies pre- and post-treatment ...
2. What are the typical costs for a DUI lawyer in Illinois? The cost of hiring a DUI lawyer in Illinois varies based on the case’s complexity. For cases where a plea deal is accepted, fees range from $700 to $1,500. If the case proceeds to trial, the fees can be between $1,5...
Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med. 2021;385:1207–18. Article CAS PubMed Google Scholar Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69–84...
Significant advancements have been made in the application of chimeric antigen receptor (CAR)-T treatment for blood cancers during the previous ten years. However, its effectiveness in treating solid tumors is still lacking, necessitating the exploration of alternative immunotherapies that can overcome th...
Within the 50 year lifetime of the Society for Environmental Geochemistry and Health (SEGH), we have seen a number of contaminants transfer from b
Summary of current adoptive cell therapies in cancer treatment. Th, helper T cell; CTL, cytotoxic T lymphocyte; PBMC, peripheral blood mononuclear cell; iPSC, induced pluripotent stem cell; hESC, human embryonic stem cell; UCB, umbilical cord blood; hPSC, human pluripotent stem cell; BM, bone...
Summary of current adoptive cell therapies in cancer treatment. Th, helper T cell; CTL, cytotoxic T lymphocyte; PBMC, peripheral blood mononuclear cell; iPSC, induced pluripotent stem cell; hESC, human embryonic stem cell; UCB, umbilical cord blood; hPSC, human pluripotent stem cell; BM, bone...
of the ECM in ATC; (2) the potential function of the main components of the ECM in ATC; (3) the potential impact of the interaction between cancer cells and the ECM in the TME on ATC progression; and (4) potential therapeutic strategies targeting aberrant ECM signaling for ATC treatment....